Medidata Services

  1. Industry-Specific Client Duties with Respect to the Services
  2. Service Specific Terms

The following provides easy access to terms applicable to Medidata customers and partners (“Clients”) use of the Services, as set forth in applicable Sales Order(s). Should a conflict arise between the terms of the applicable Sales Order and the terms below, the Sales Order shall control.

1. Industry-Specific Client Duties with Respect to the Services. Client shall:

  • be solely responsible, and assume all liability for, all operational aspects, decisions, results and outcomes of its clinical trial(s) and related businesses including, as applicable (i) the design, structure and content of all protocols; (ii) obtaining the legal basis for Processing Client Data, such as gaining consents or providing notices for study participants and Authorized Users required under Privacy Laws or good clinical practice (GCP); (iii) the collection, quality and accuracy of Client Data, including determination of the specific data collected; (iv) data protection agreements with any other controllers; (v) the manufacture, supply, and handling of investigational products; (vi) regulatory submissions; and (vii) ensuring that Client Data accessible via the Services is accessed only by appropriate Authorized Users. For purposes of this provision, a)‘Privacy Laws’ means all laws and regulations applicable to the Processing of Personal Data under the Agreement, including the General Data Protection Regulation (Regulation (EU) 2016/679) (the “GDPR”), all as amended from time to time, and b) “Processing’ means any operation or set of operations which is performed upon Personal Data, whether or not by automatic means, including the collection, recording, organization, storage, updating, modification, retrieval, consultation, use, transfer, dissemination by means of transmission, distribution or otherwise making available, merging, linking as well as blocking, erasure or destruction.
  • obtain and provide Medidata with relevant information and materials, including protocols and amendments, data, third party licenses (including for specific medical dictionaries) or consents, and timely feedback, as reasonably required in order for Medidata to provide the Services.
  • be responsible for having in place backup processes and mechanisms to perform critical functions to support the safety of study participants or uninterrupted clinical trial operations in the event of an unexpected outage.
  • not export or re-export, directly or indirectly, any Service or related Documentation if such export or re-export requires an export license or other governmental approval pursuant to Export Control Regulations without first obtaining such license or approval. For purposes of this provision, ‘Export Control Regulations’ means all applicable export control laws and regulations, and sanctions programs worldwide, including the United States Export Administration Regulations (EAR) and the Office of Foreign Assets Control (OFAC) Specially Designated Nationals sanctions, and the European Union Council Regulation (EC) No 428/2009.

2. Service Specific Terms:

Medidata Services Terms Revision History:

Date

Description of Changes

3-Feb-2023

Industry-Specific Client Duties:  Added export provisionDevice Services and Other Subscription Services for Instruments:  For one-time scope reduction for such Services, deleted Client obligation to pay accrued non-cancellable third party fees.

3-Feb-2023

Device Provisioning Termination: Added definition of “Shipped”Unused Device Plan: Updated Device transfer fee

3-Feb-2023

SensorCloud Services:  Removed processing of De-identified Raw Data and De-identified Process Data in Medidata Uses to create Combined Data.

30-May-2023

Site Payments Services: Added Money Transfer Services terms

13-Mar-2024

Industry-Specific Client Duties with Respect to the Services: Grammatical changes; including to section (i), (ii) Revised definition of “Privacy Laws” Addition of definition of “Processing”

13-Mar-2024

Service Specific Terms: Added “Circuit Clinical (TrialJourney, DCT Site Network) to the Patient Cloud Services

13-Mar-2024

Grant Manager Applications: Revised terms for required Client Data to be submitted for use of the Application Services

13-Mar-2024

Patient Cloud Services: For Patient Cloud Applications added Sensor Cloud and Circuit Clinical Applications Added (i) requirement to provide study Protocols to Medidata Updated the terms required for ‘bring your own device’ strategy Updated the minimum device requirements for iPhone and Android for ePRO/eCOA and myMedidata Application Services

13-Mar-2024

Patient Cloud Services – Device Services: updated definition of “Device Provisioning” Removed all references to BioStamp nPoint (Remote Kit) and BioStamp Adhesives Clarified requirement of thirty (30) days to return devices for early study termination Added disclaimer of country specific device requirements may vary by country

13-Mar-2024

Patient Cloud Services – Device Support: Renamed and defined “Device Support” to “Patient Cloud Helpdesk Support”

13-Mar-2024

Device Services and Other Subscription Services Adjustment: Defined “one-time adjustment” is applicable upon initial contract of Device Services (“Transaction Effective Date”)

13-Mar-2024

Device Provisioning Termination: Added Transaction Effective Date to the Termination process.

13-Mar-2024

Unused Device Plan: Added Transaction Effective Date to the Unused Device Plan process

13-Mar-2024

Site Payments General: Modified the definition of “Payment” to incorporate ‘unique Payee associated with a site’ Removed definition of “Site Activation”

13-Mar-2024

Application Services: Site Payments (including Disbursements): Removed definition of “Country/Currency Pairing”
Removed definition of “Off-cycle Payment”
Removal of “Site Payments (including Disbursements) Thresholds and Overage Rates” language and rate chart

1-May-2024

ROAD: Terms removed

25-Nov-2024

Instrument Licensing – License Procurement: Added Service specific terms for Instrument license holder invoice instructions.

25-Nov-2024

Device Provisioning Termination: Updated terms to clarify the Device Provisioning Credit and Unused Device Plans.